Birgit M. Schaefer

669 total citations
30 papers, 537 citations indexed

About

Birgit M. Schaefer is a scholar working on Cell Biology, Cancer Research and Molecular Biology. According to data from OpenAlex, Birgit M. Schaefer has authored 30 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cell Biology, 10 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Birgit M. Schaefer's work include Skin and Cellular Biology Research (10 papers), Protease and Inhibitor Mechanisms (9 papers) and Wound Healing and Treatments (7 papers). Birgit M. Schaefer is often cited by papers focused on Skin and Cellular Biology Research (10 papers), Protease and Inhibitor Mechanisms (9 papers) and Wound Healing and Treatments (7 papers). Birgit M. Schaefer collaborates with scholars based in Germany, United States and Switzerland. Birgit M. Schaefer's co-authors include Michael D. Kramer, Jeannette Reinartz, Yue Sun, Dobrila Nešić, Irena Sailer, Nikola Saulačić, Michael D. Kramer, Manfred Dietel, Jutta M. Rox and Reinhard Wallich and has published in prestigious journals such as The Journal of Urology, Journal of Investigative Dermatology and Experimental Cell Research.

In The Last Decade

Birgit M. Schaefer

30 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit M. Schaefer Germany 15 200 110 107 69 63 30 537
Jyrki Heino Finland 6 241 1.2× 189 1.7× 93 0.9× 59 0.9× 48 0.8× 7 716
Hanneke N. Monsuur Netherlands 12 273 1.4× 96 0.9× 115 1.1× 40 0.6× 65 1.0× 17 635
Martina Ghetti Italy 14 201 1.0× 100 0.9× 91 0.9× 63 0.9× 27 0.4× 24 493
Peter McCroskery United States 12 179 0.9× 246 2.2× 149 1.4× 78 1.1× 112 1.8× 18 904
Juan Luis Callejas‐Valera United States 12 299 1.5× 97 0.9× 225 2.1× 59 0.9× 30 0.5× 19 693
Suzan Commandeur Netherlands 9 203 1.0× 38 0.3× 118 1.1× 68 1.0× 55 0.9× 11 549
Kyomi Ibaraki United States 12 363 1.8× 80 0.7× 111 1.0× 63 0.9× 25 0.4× 15 719
Barbara Johnson‐Wint United States 11 219 1.1× 130 1.2× 65 0.6× 55 0.8× 26 0.4× 12 618
Carrie Fang United States 11 151 0.8× 75 0.7× 45 0.4× 112 1.6× 16 0.3× 14 493
Mary DeRome United States 15 397 2.0× 66 0.6× 124 1.2× 56 0.8× 29 0.5× 23 676

Countries citing papers authored by Birgit M. Schaefer

Since Specialization
Citations

This map shows the geographic impact of Birgit M. Schaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit M. Schaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit M. Schaefer more than expected).

Fields of papers citing papers by Birgit M. Schaefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit M. Schaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit M. Schaefer. The network helps show where Birgit M. Schaefer may publish in the future.

Co-authorship network of co-authors of Birgit M. Schaefer

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit M. Schaefer. A scholar is included among the top collaborators of Birgit M. Schaefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit M. Schaefer. Birgit M. Schaefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuttenberger, Johannes, Elżbieta Polska, & Birgit M. Schaefer. (2012). A novel three-dimensional bone chip organ culture. Clinical Oral Investigations. 17(6). 1547–1555. 14 indexed citations
2.
Ahr, A., et al.. (2006). Outcome of preterm and term neonates of mothers with malignant diseases diagnosed during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine. 19(2). 101–103. 7 indexed citations
3.
Noske, Aurelia, Wilko Weichert, Christine Sers, et al.. (2006). Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: Increased expression of AKT in advanced ovarian cancer. Cancer Letters. 246(1-2). 190–200. 45 indexed citations
4.
Schaefer, Birgit M., et al.. (2001). Expression of the Helix–Loop–Helix Protein ID1 in Keratinocytes Is Upregulated by Loss of Cell–Matrix Contact. Experimental Cell Research. 266(2). 250–259. 14 indexed citations
5.
Friedl, Peter, et al.. (2001). Molecular and Functional Characterization of the Four-Transmembrane Molecule L6 in Epidermal Keratinocytes. Experimental Cell Research. 267(2). 233–242. 11 indexed citations
6.
Schaefer, Birgit M., et al.. (2000). Immunohistochemical and molecular characterization of cultured keratinocytes after dispase‐mediated detachment from the growth substratum. Experimental Dermatology. 9(1). 58–64. 14 indexed citations
7.
Schaefer, Birgit M., Christian Lorenz, Walter Back, et al.. (1998). AUTOLOGOUS TRANSPLANTATION OF UROTHELIUM INTO DEMUCOSALIZED GASTROINTESTINAL SEGMENTS: EVIDENCE FOR EPITHELIALIZATION AND DIFFERENTIATION OF IN VITRO EXPANDED AND TRANSPLANTED UROTHELIAL CELLS. The Journal of Urology. 159(1). 284–290. 28 indexed citations
9.
Reinartz, Jeannette, et al.. (1996). Plasminogen Activator Inhibitor Type-2 (PAI-2) in Human Keratinocytes Regulates Pericellular Urokinase-Type Plasminogen Activator. Experimental Cell Research. 223(1). 91–101. 22 indexed citations
10.
Schaefer, Birgit M., et al.. (1996). Rapid Normalization of Epidermal Integrin Expression After Allografting of Human Keratinocytes. Journal of Investigative Dermatology. 107(3). 423–427. 3 indexed citations
11.
Schaefer, Birgit M., et al.. (1996). α2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds. Archives of Dermatological Research. 288(3). 122–128. 19 indexed citations
12.
Reinartz, Jeannette, et al.. (1996). Upregulation of Cell-Surface-Associated Plasminogen Activation in Cultured Keratinocytes by Interleukin-1βand Tumor Necrosis Factor-α. Experimental Cell Research. 223(2). 395–404. 45 indexed citations
13.
Schaefer, Birgit M., et al.. (1996). Plasminogen activator inhibitor type-2 in the lesional epidermis of lupus erythematosus.. PubMed. 134(3). 411–9. 10 indexed citations
14.
Schaefer, Birgit M., et al.. (1996). Dispase-Mediated Basal Detachment of Cultured Keratinocytes Induces Urokinase-type Plasminogen Activator (uPA) and Its Receptor (uPA-R, CD87). Experimental Cell Research. 228(2). 246–253. 9 indexed citations
15.
Schaefer, Birgit M., et al.. (1996). Plasminogen activator system in pemphigus vulgaris. British Journal of Dermatology. 135(5). 726–732. 25 indexed citations
16.
Herijgers, Nicole, et al.. (1995). Cell Surface-Bound Urokinase-Type Plasminogen Activator Facilitates Infiltration of Freshly Isolated Granulocytes into a Fibrin Matrix. Immunobiology. 194(4-5). 363–375. 7 indexed citations
17.
Seidel, André, et al.. (1995). Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 426(3). 249–56. 42 indexed citations
19.
Dietel, Manfred, et al.. (1994). Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA. Journal of Cancer Research and Clinical Oncology. 120(5). 263–271. 16 indexed citations
20.
Dietel, Manfred, et al.. (1993). In vitro prediction of cytostatic drug resistance in primary cell cultures of solid malignant tumours. European Journal of Cancer. 29(3). 416–420. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026